Skip to content

vitamin D administration on chronic liver disease

Effects of Vitamin D administration on patients with chronic liver disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs031200015
Enrollment
200
Registered
2020-04-15
Start date
2020-04-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic liver disease chronic liver disease , vitamin D

Interventions

Sponsors

Itokawa Norio
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with chronic liver disease 20 years old or older, under 85 years old Both hospitalization / outpatient Patients with serum 25 (OH) D3 concentration deficiency less than 20 ng / ml

Exclusion criteria

Exclusion criteria: Hepatic encephalopathy more than 3 Total bilirubin value >3 mg/dl Patien with decrease of the protein composition ability in the liver The patient allergic to milk The patient who is nursing and pregnant Patient with uncotrolled HCC or other malignant tumor Uncontrolled heart failure patient Uncontrolled hypertension or diabetes Patient with Chronic renal failure Patient of hypercalcemia Patient with hyperthyroidism Patient who already takes other vitamin D Patien who takes the drug that combination with the vitamin D preparation is contraindicated Patient with acute liver failure Patient who were judged unsuitable by test responsibility doctor

Design outcomes

Primary

MeasureTime frame
Skeletal muscle mass, grip, Liver fibrosis

Contacts

Public ContactTOMOMI OKUBO

Nippon Medical Chiba Hokuso Hospital

nms.hokuso@gmail.com+81-476991111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026